Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Next Previous
X
Search
Trial Profile

A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2025

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Burixafor (Primary) ; Propranolol (Primary) ; Granulocyte colony-stimulating factor receptor agonists
  • Indications Multiple myeloma
  • Focus Pharmacokinetics
  • Sponsors GPCR Therapeutics

    • Most Recent Events

    • 22 Jan 2025 According to an Exicure Inc media release, after completing patient treatment, company will conduct follow-up observations until July and then start data analysis,
    • 22 Jan 2025 According to an Exicure Inc media release, company announced (entered into a Share Purchase Agreement with GPCR Therapeutics Inc) , two additional patients will receive treatment in January. Company plans to complete the administration of GPC-100 to 20 patients by April and aim to announce the clinical trial results in September.
    • 24 Apr 2024 Planned End Date changed from 30 Jun 2024 to 30 Jun 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top